Approval · Notice of Compliance 5643 · 1994
MICRO +4 INJECTION: Notice of Compliance 5643
Issued May 9, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5643
- Date
- May 9, 1994
- Company
- Sabex Inc.Boucherville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Multi-trace element
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MICRO +4 INJECTION | 02091135 | Marketed |
| MICRO +4 INJECTION | 02091143 | Cancelled Post Market |
Medicinal ingredients
- ZINC SULFATE 1 MG per ML
- CUPRIC SULFATE 0.4 MG per ML
- MANGANESE SULFATE 0.1 MG per ML
- CHROMIC CHLORIDE 4 MCG per ML
- CHROMIC CHLORIDE 10 MCG per ML
- CUPRIC SULFATE 1 MG per ML
- MANGANESE SULFATE 0.5 MG per ML
- ZINC SULFATE 5 MG per ML